3,6-Dibromo-2-methylpyridine

3,6-Dibromo-2-methylpyridine is a key intermediate in organic synthesis. 3,6-Dibromo-2-methylpyridine can be used in the study of pulmonary fibrosis and PRC2-dependent cancers[1][2].

Product Specifications

CAS Number

[39919-65-8]

UNSPSC

12352200

Hazard Statement

H302, H315, H319, H335

Target

Biochemical Assay Reagents; Drug Intermediate

Type

Biochemical Assay Reagents

Related Pathways

Others

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/3-6-dibromo-2-methylpyridine.html

Purity

99.58

Solubility

10 mM in DMSO

Smiles

CC1=C(Br)C=CC(Br)=N1

Molecular Formula

C6H5Br2N

Molecular Weight

250.92

Precautions

H302, H315, H319, H335

References & Citations

[1]Cheng PTW, et al. Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases. J Med Chem. 2021 Nov 11;64 (21) :15549-15581. |[2]Hsu JH, et al. EED-Targeted PROTACs Degrade EED, EZH2, and SUZ12 in the PRC2 Complex. Cell Chem Biol. 2020 Jan 16;27 (1) :41-46.e17.